These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 3292151

  • 1. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J, Kugel M, Schoeppe W, Brunkhorst R, Samtleben W, Bramsiepe P, Scigalla P.
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfåffl W, Baldamus CA, Scigalla P.
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract] [Full Text] [Related]

  • 3. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW.
    N Engl J Med; 1987 Jan 08; 316(2):73-8. PubMed ID: 3537801
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT.
    Contrib Nephrol; 1989 Jan 08; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ, Petersen J.
    West J Med; 1992 Aug 08; 157(2):154-7. PubMed ID: 1441466
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Investigating erythropoietin resistance.
    Koury MJ.
    N Engl J Med; 1993 Jan 21; 328(3):205-6. PubMed ID: 8417388
    [No Abstract] [Full Text] [Related]

  • 11. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D, Djukanović Lj, Lezajić V.
    Srp Arh Celok Lek; 1992 Jan 21; 120(9-10):281-5. PubMed ID: 1306020
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin 1991--an overview.
    Eschbach JW.
    Am J Kidney Dis; 1991 Oct 21; 18(4 Suppl 1):3-9. PubMed ID: 1928076
    [Abstract] [Full Text] [Related]

  • 13. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D, Hauglustaine D, Sennesael J.
    Neth J Med; 1988 Aug 21; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract] [Full Text] [Related]

  • 14. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP.
    Semin Nephrol; 1989 Mar 21; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [Abstract] [Full Text] [Related]

  • 15. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA, Salim S, Mathew T.
    J Assoc Physicians India; 1992 Jan 21; 40(1):42-3. PubMed ID: 1634463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu, Klepikov PV, Lashutin SV.
    Ter Arkh; 1992 Jan 21; 64(6):90-1. PubMed ID: 1440349
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.